pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Lead Candidate
drug
save

Lead Candidate

Preclinicalupdated 3mo ago
by MaavRx Ltd
Preclinical
community read0 votes

indications

indications
Parkinson's Disease

all catalysts(0)

nothing on the calendar yet

News(10)

  • After slimming down workforce, Aardvark scraps phase 3 trials as wait for next steps drags on
    Aardvark Therapeutics has confirmed it is walking away from recently terminated phase 3 trials, telling investors it has no plans to resume the studies “as previously designed” as it works to find…
    fiercebiotech · 6h ago
  • Aura, Schrödinger trim workforces
    Follow along as BioSpace tracks job cuts and restructuring initiatives.
    biospace · 1d ago
  • Epicrispr, Infinimmune snag combined $165M in VC cash
    Epicrispr Biotechnologies is working on an epigenetic medicine for facioscapulohumeral muscular dystrophy, while Infinimmune will advance a pair of antibodies for atopic dermatitis.
    biospace · 1d ago
  • Aura lays off 20% of workforce, rejigs C-suite amid R&D refocus on eye cancer
    Aura Biosciences is refocusing under its recently installed CEO, laying off 20% of its employees and overhauling its C-suite as it narrows its focus on ocular oncology.
    fiercebiotech · 1d ago
  • Regeneron backs $75M series A for antibody upstart Infinimmune
    Infinimmune has amassed further fuel to power its antibody discovery engine, netting a $75 million series A headlined by Regeneron’s venture arm.
    fiercebiotech · 1d ago
  • Jazz commits up to $1.3B to buy Actio, bolster epilepsy pipeline
    Jazz Pharmaceuticals is reaching into its wallet once again, this time buying Actio Biosciences and an experimental therapy for KCNT1+ epilepsy, a form of the disease with no FDA-approved treatments.
    biospace · 2d ago
  • ITM neuroendocrine tumor drug spurned by FDA over manufacturing qualms
    The FDA has denied ITM Isotopes Technologies’ lead pipeline candidate for a rare group of tumors due to qualms over the drug’s manufacturing.
    fiercebiotech · 2d ago
  • Jazz pays $820M to buy Actio, adding clinical-stage asset to orchestra of epilepsy therapies
    Jazz Pharmaceuticals is adding to its orchestra of epilepsy treatments with the acquisition of Actio Biosciences for $820 million upfront.
    fiercebiotech · 2d ago
  • BlossomHill, Latigo outshine IPO expectations with oversubscribed debuts
    Two growing biotechs blasted through their IPO expectations Friday, with Blossom Hill Therapeutics and Latigo Biotherapeutics each raising at least 30% more than expected in their stock market debuts.
    fiercebiotech · 5d ago
  • Braveheart pumps more life into biotech IPO market with $382M expected debut
    Braveheart Bio has emerged on the Nasdaq with an upsized expected initial public offering—marking the public entrance of the twenty-second biotech this year.
    biospace · 6d ago
view all news mentions →
indication
Parkinson's Disease
phase
preclinical
Data sources
ClinicalTrials.gov
last refreshed 1h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?